Bionano Genomics Inc expected to post a loss of $1.03 a share - Earnings Preview

Bionano Genomics

08/08/2023 03:05

* Bionano Genomics Inc  BNGO.OQ   BNGO.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 9. 
    * The San Diego California-based  company is expected to
report  a
24.4% increase in revenue to $8.295 million from $6.67 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. The company's guidance on May 9 2023, for the
period ended June 30, was for revenue between $7.80 million and
$8.30 million.
    * ​Refinitiv's mean analyst estimate for Bionano Genomics
Inc is
for a loss of $1.03 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bionano
Genomics
Inc is $30​, above​ its last closing price of $4.67. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -1.10       -1.10      -1.20     Missed  -9.1
 Dec. 31 2023  -1.14       -1.10      -1.30     Missed  -18.2
 Sep. 30 2022  -1.18       -1.15      -1.10     Beat    4.3​
 Jun. 30 2022  -1.03       -0.91      -1.10     Missed  -20.4
 ​​Mar.        -0.87       -0.75      -1.10     Missed  -46.7
 31 2022                                                
 Dec. 31 2021  -0.64       -0.65      -0.80     Missed  -23.6​
 Sep. 30 2021  -0.57       -0.57      -0.74     Missed  -30.6
 Jun. 30 2021  -0.46       -0.45      -0.60     Missed  -32.6
 This summary was machine generated August 8 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated